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Abstract
The community pharmacists (CPs) are legally responsible to hand out a wide range of 
ready-made prescription medications to patients. Additionally, CPs are also involving in 
advocating customers who determine to self-medicate. Interestingly, it is also noted that 
CPs in developed countries like the United Kingdom, Germany, and Canada have per-
formed more than these services. What are the extended community pharmacy services 
available? What are the barriers and perceptions of these extended services? It is rationale 
to explore such issues globally since it might have potential to give some possible course 
of action to CPs to incorporate more values to the contemporary services.
Keywords: community pharmacists, extended services, barriers, perception, global
1. Introduction
In the healthcare system, the pharmacists are responsible to audit an instruction inscribed by 
the medical practitioners to determine potential inappropriate written prescriptions [1]. Such 
responsibilities are likely to have a profound effect on the success of the healthcare modus 
operandi since it has potential to wipe out prescribing incongruous medication events [2]. 
The proceeding is being noticed in the hospital but not at all in non-hospital independent 
settings. For example, in the developing country like Malaysia, the community pharma-
cists (CPs) are rarely auditing the written instruction inscribed by the general practitioners 
(GPs) because GPs are legally given the right to prescribe and dispense medications to their 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
patients [3]. In other words, GPs are performing their exercises regularly in the absence of 
CPs to audit their prescribing activities. Such exercises might cause their patients to vulner-
able experience potential unwanted effects of improper prescribing and it was noted in an 
earlier study which corroborates the potentially inappropriate prescribing among the long-
term care Irish patients [4]. Therefore, the roles of CPs to audit such improper prescribing 
among GPs are crucial accountabilities in the healthcare system. Nevertheless, the health-
care modus operandi must act in accordance with the mandatory regulation even though 
such modus operandi might have potential to inflict harm on anyone else.
As CPs, they are also accountable to advocate the consumers with respect to the safe use of medi-
cation, its effectiveness, and cost-effective affair. Such responsibilities were noted in earlier stud-
ies throughout the world. For example, it is noted that CPs in the United Kingdom are pointing 
out their role in maintaining safe use of medication among the consumers [5]. In Canada, CPs are 
executing the role to corroborate the prescriptions are filled up with quality, safe, and effective 
medications [6]. Additionally, it is noted that CPs in Finland are having the skills to ensure the 
rising cost that will not restrict the access to medications by the consumers [7]. Such honorable 
responsibilities are magnifying the potential roles of CPs in the healthcare system.
Instead of the roles, it is also a crucial intentionality to determine divergent roles which might be 
performed in the developed and developing countries. Such dissimilar performance might make 
it easier for CPs to offer particular services in their community pharmacy settings. Furthermore, 
the services might have potential to intensify the reputation of CPs as a healthcare provider 
in the eyes of other healthcare practitioners, policymakers, and consumers. Additionally, the 
extended services might potentially enlarge the earnings scale in community pharmacy settings.
2. Methods of content analysis
A systematic search was performed via international and national literature reviews and 
studies using Google Scholar and PubMed as an electronic database, searching for abstracts 
in English from January 2005 till January 2017 for the international search [8] and January 
2006 till May 2017 for the national search [3]. The general search terms used were: com-
munity pharmacist; extended roles; extended services; expansion roles; expansion services; 
perception; perspective; attitudes; barriers; limitation; expanded pharmacy services; pharma-
cist care services; enhanced pharmacy services; private pharmacies; future services; public 
Population CPs, GPs, customers
Phenomenon of interest CPs’ extended services; perceptions among CPs, customers, and GPs of extended services. 
Identifying barriers toward extended services
Primary outcome 
measures
The outcome measures but not restricted to it were: (1) to describe extended services; (2) 
to describe perceptions among CPs, customers, and GPs toward extended services; (3) to 
identify barriers toward extended services
Types of studies Quantitative and qualitative studies; article reviews
CPs, community pharmacists; GPs, general practitioners.
Table 1. Criteria for inclusion of studies in the report.
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health; healthcare systems; review; pharmacy; community pharmacy; CPs; patient counsel-
ing; continuing pharmacy education; disease management; intervention; and healthcare. The 
abstracts were evaluated by the scholar researcher, searching for relevant materials that fitted 
with the inclusion criteria as depicted in Table 1. The abstracts that concordance with the 
inclusion criteria were assessed for full texts. Then, another two scholar researchers evaluated 
in detail the contents of each text, searching for materials that concordance with the criteria in 
Table 1. These inclusive texts were reflected in this report. The flow of the searching process 
was reflected in Figures 1 and 2.
Figure 1. Flow diagram for international search.
Figure 2. Flow diagram for National Search.
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3. Extended pharmacy services
It is noted that there is a wide range of extended pharmacy services available in many coun-
tries throughout the world as illustrated in Table 2 [9–37]. In the absence of Pakistan’s sce-
nario [38], other such extended services divulge the true color of CPs’ knowledge and skills 
in an authentic practice. For example, it is noted that CPs in Australia are operating supreme 
services such as anticoagulant and drug-level monitoring, ostomy counseling, chemotherapy, 
parenteral, and nutrition preparation. In Canada, it is noted that CPs are executing the roles 
to advocate their customers for alcohol consumption, smoking cessation, physical activities, 
and immunization. Interestingly, CPs in the developing country like Sudan are making avail-
able services such as emergency oral contraception counseling, hyperlipidemia monitoring, 
and hypertension care. However, the prominence extended service notified in the table is the 
provision of pharmaceutical care (PC) in community pharmacy settings as noted in Japan, 
Hong Kong, China, and the United Arab Emirates. Such extended service is also notified in 
other countries like Peru [39] and Estonia [40]. It divulges PC as a paramount importance to 
be performed in the healthcare system side-by-side with other extended services.
There are a lot of earlier studies which disclose such extended service has accomplished posi-
tive end results via an authentic practice. For example, it is noted that CPs in Spain are having 
the quality necessary to exalt medication adherence among the hypertensive patients [41]. In 
Australia, CPs have executed the role to ameliorate the clinical and humanistic net results among 
patients who possess type 2 diabetes [42]. Another pharmaceutical care study in Malaysia dis-
closes the potential of CPs to diagnose a wide range of potential undesirable drug-related prob-
lems among their customers [43]. It is also notified that there is a review article which divulges 
the positive impact of smoking cessation program performed by CPs [44]. Consequently, these 
significant positive impacts are putting on a screen for the consumers and other healthcare 
practitioners to acknowledge the roles of CPs in community pharmacy settings. Additionally, it 
might inspire other CPs to persuade the exact service for the benefits of their customers.
Even though there are some CPs who might operate their extended services without demand-
ing dollars as a price from their customers for a service rendered, it is essential to reimburse 
CPs for their knowledge and skills. For example, an earlier review article has pointed out 60 
reimbursement programs for CPs in the United States, Canada, Europe, Australia, and New 
Zealand [45]. Such reimbursement comprises of payment as such for emergency contracep-
tion counseling, advice on minor ailments, comprehensive medication management, medica-
tion review, follow-up visit, and time-dependent fee. It is noted that there are variable charges 
in different countries for the similar extended services. It discloses that the charges must take 
into account of knowledge, skills, and time exercised by CPs to perform the extended services 
[46]. Consequently, CPs are given the image as a professional healthcare practitioner like GPs 
rather than as an entrepreneur.
Nevertheless, it is crucial to perform a systematic inquiry to notify the facts of barriers and per-
ception among the consumers and other healthcare providers so as to establish the truth of these 
extended services. Such inquiry might intensify the truth operation of these extended services 
in an authentic practice. Over and above that, the facts and figures which put into picture might 
have potential to manoeuvre CPs to instigate a strategy formula to get rid of them.
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Extended services: Country published [Article #]
Determine DRP: Jordan [14], Netherlands [12], China [15], Sudan [23], UAE [22], Mal [32]
Legal right to prescribe selected medications: United Kingdom [11], Aust [16], South Africa [18]
Proffer the pharmaceutical care concept: Japan [28], HK [29], China [15], UAE [20, 22]
Managing a SC program: Japan [28], Aust [13], Canada [17], Sudan [23], UAE [19], Mal [30, 32, 35]
Advising on healthy diets: Canada [17]
Organizing aboriginal health services: Aust [13]
Counseling on alcohol consumption: Canada [17]
Running an anticoagulation monitoring: Aust [13]
Deliver an asthma care: Aust [13], UAE [22], Mal [30]
Offering a body piercing service: Aust [13]
Chemotherapy preparation: Aust [13]
Community health education: Aust [13], Sin [9], HK [27], China [15], Sudan [23], UAE [22], Mal [30, 32]
Community clinic service: Aust [13], Mal [36, 37]
Counseling on physical activities: Canada [17], Mal [30, 35]
Diabetes care service: Aust [13], Canada [17], UAE [19, 22], Mal [30]
Service for patients discharged from hospital settings: Aust [13], Netherlands [12]
Drug-level monitoring or kinetic dosing service: Aust [13]
Emergency oral contraception counseling: Canada [17], Sudan [23]
Geriatric care service: Aust [13], Japan [26, 28]
Harm reduction methadone service: Aust [13]
Herbal and nutritional supplement counseling: Aust [13], UAE [19], Mal [30, 35]
Hyperlipidaemia monitoring service: Aust [13], Canada [17], Sudan [23]
Hypertension care service: Aust [13], Canada [17], Sudan [23], Mal [30, 35]
Drug misuse counseling: Mal [30]
Immunization program service: Canada [17], UAE [22], Mal [30]
Referring patients to GPs: Mal [32]
Lifestyle modification counseling: HK [27], Canada [17], UAE [19]
Medication counseling or review: Nepal [25], Netherlands [12], Sin [9], HK [27, 29], China [15], Russia [10], Sudan 
[23], UAE [19, 22], Mal [30, 31, 32, 34]
Minor ailment or self-care consultation: Sin [9], HK [29], China [15], UAE [19], Mal [32]
Naturopathy counseling: Aust [13]
Nutritional support including parenteral and enteral nutrition service: Aust [13]
Osteoporosis care service: Aust [13], Japan [26]
Ostomy counseling: Aust [13]
Pediatric pharmacy service: Aust [13]
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4. Barriers and perceptions of extended community pharmacy 
services
There is a wide range of barriers to the performance of extended services notified as illus-
trated in Table 3. Such barriers are a serious impediment to the extended service’s progress 
and it is noted that CPs, GPs, and consumers can be the origins of the barriers. For example, 
CPs in the United Kingdom, Australia, Belgium, Nepal, Netherlands, Singapore, Canada, and 
the United Arab Emirates specify a lack of time to spend with their customers might be the 
paramount barrier to the extended services. Additionally, CPs in the United Kingdom and 
Australia have to reinforce self-confidence to perform such services since there is a potential 
lack of on-going training for them. Interestingly, it is notified that CPs in Russia and Sudan 
are incorporating a lack of clinical component in the pharmaceutical education as the obsta-
cle which puts a stop to the extended services. Foremost, it is noted that CPs in the United 
Kingdom, Singapore, the United Arab Emirates, Canada, Australia, and China might lose their 
enthusiasm to implement such extended services due to reimbursement affair. Furthermore, 
CPs in the United Kingdom and Canada intensify the extended services and require financial 
support. Therefore, it is crucial intentionality to determine such barriers and CPs must have 
the devotion to rectify the situation with strong feeling and belief of each extended service that 
can benefit their customers at all.
Most prominent in rank, it is noted that CPs might not have an interest to execute the extended 
services due to their absence of knowledge and skills as illustrated in Table 3. The reasons 
Pain management service: Aust [13]
Pharmacist-led patient self-management of chronic disease: HK [27, 29]
Psychiatric pharmacy service: Aust [13], Belgium [24]
Sexual health counseling: Canada [17]
Skin-care management service: Aust [13]
Specialized compounding service: Aust [13], UAE [22]
Weight management counseling: Aust [13], Canada [17], UAE [19], Mal [30]
Wound care service: Aust [13], UAE [19]
Monitoring medication outcome: Mal [32]
Providing medication information to GPs: Mal [32]
Oral health counseling: Mal [30]
Special population counseling: Mal [30]
Breast cancer counseling: Mal [33]
GPs, general practitioners; UAE, United Arab Emirates; HK, Hong Kong; Mal, Malaysia; Aust, Australia; Sin, Singapore; 
DRP, drug-related problem; SC, smoking cessation; #, number.
Table 2. Details of countries which indicate extended pharmacy services.
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Barriers: Country published (Article #)
Lack of on-going interaction between CPs and customer: Jordan [14], Japan [28], Pakistan [38], HK [27, 29], Canada 
[17]
Not regular customers: Canada [17]
Customers do not like to be condemned for their lifestyles: Canada [17]
CPs put more effort into product-oriented service: Jordan [14], Japan [28], Sin [9], HK [27], Russia [10], UAE [19, 20]
Customers are in rush and do not have much time to interact with pharmacists: Canada [17]
CPs are not always available at pharmacies: Canada [17]
Pharmacy program in university is basically product-oriented rather than patient-oriented: China [15]
Lack of clinical components in pharmacy education: Russia [10], Sudan [23]
Absence of legal regulation to conserve customer medication documentation: Jordan [14]
Lack of time to counsel: UK [11], Aust [13], Belgium [24], Nepal [25], Netherlands [12], Sin [9], Canada [17], UAE [19]
Owner does not have the interest to provide such extended services: Canada [17], Russia [10], Mal [30]
Customers do not have an idea about benefit of such extended services: Canada [17]
Lack of interrelationship among the CPs: Sin [9]
Shortage of pharmacists: Aust [13], Pakistan [38], Canada [17], China [15], Mal [34]
Shortage of supporting staffs: UAE [19], Mal [33]
Lack of financial support: UK [11], Canada [17], Mal [33, 36, 37]
Lack of self-confidence to execute such services: UK [11], Aust [13], South Africa [18]
Low perception of self-competence: UK [11], South Africa [18]
CPs have been overworking: Canada [17]
Language barrier: Mal [34]
Lack of working relationship with other HPs: UK [11], Aust [13], Belgium [24], Sin [9], HK [27], Canada [17]
Lack of managing support: UK [11], Mal [30]
Such extended services are not composed of a conservative pharmacy profession: Aust [13], China [15]
On-going searching for a location to perform: UK [11]
Competition with colleagues for a location to perform: UK [11]
Lack of confidence or trust among customers: UK [11], Belgium [24], Nepal [25], HK [29], UAE [20, 22]
Customers are not ready to undergo a chance in the conservative practice: Canada [17]
Customers reject to reimburse for such extended service: Aust [13]
Lack of reimbursement scheme: UK [11], Aust [13], Belgium [24], Sin [9], UAE [19], Canada [17], China [15], Mal [30]
Lack of clinical supporting tools: Canada [17], South Africa [18]
Lack of recognition as a supreme healthcare practitioner: Pakistan [38], Sin [9], HK [27, 29], Sudan [23], UAE [21, 22]
Lack of continuing support: UK [11]
Having existence of many technical burdens to be sorted out: UK [11], Canada [17]
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are putting into the frame that it is crucial to initiate a strategy formula in order to eliminate 
the barrier toward extended services. In absence of the strategy formula, CPs might not have 
the opportunity to undergo phenomenal experience via extended services. Therefore, in our 
opinion, it is necessary to give intellectual to CPs who can take the first step to commerce a tri-
age action mode as an earlier extended service in community pharmacy settings. Such action 
mode is a critical exercise because CPs are always in the right position to act as a ‘gate-keeper’ 
to the entire healthcare system. Following the sequence, it is believed that CPs might make 
a start to acquire knowledge and skills in dissimilar extended services in order to serve the 
customers. Nonetheless, it is necessary to institute a fundamental procedure for CPs to follow 
in making an accurate triage action plan. The procedure should be simple and easier to be 
carried out in the frenetic surrounding.
Nevertheless, the consumers in point of fact are the paramount importance to the provision of 
extended services in community pharmacy settings. Such extended services turn to be ineffec-
tual if the consumers refuse to admit the true benefits of such services. As a result, the consum-
ers might testify against such extended services via their negative justification. For example, 
as illustrated in Table 3, it is noted that the consumers in Canada possess insufficient time 
to be in contact with CPs and such extended services are not adjudged to be the recipient to 
ameliorate their health status. Such feeling and beliefs are obstacles to the normal progress of 
Lack of knowledge and skills: Aust [13, 16], Belgium [24], China [15], Pakistan [38], Nepal [25], HK [27], Canada [17], 
Russia [10], Sudan [23], UAE [22], Mal [33, 34]
Lack of competence to formulate a drug therapy plan: UK [11]
Other HPs confuse with recent extended services: UK [11], Aust [13], HK [29], UAE [21], Sudan [23], Mal [32, 36, 37]
Lack of on-going training program: UK [11], Japan [28], Aust [13], HK [27], Sudan [23], Mal [30, 33, 34]
Lack of profitability: Mal [30, 33]
Government/organizational puts a stop to such extended services: UK [11], Pakistan [38], Sin [9], HK [27, 29], UAE 
[19]
Lack of an access to medication record: UK [11], Belgium [24], Sin [9], Aust [13], HK [27], Canada [17], Sudan [23]
Other HPs have a negative way of thinking: UK [11], Aust [16], Pakistan [38], HK [27], Canada [17], UAE [21, 22]
Lack of a return performance evaluation: UK [11]
Such extended services confusticate the customers: UK [11], HK [27, 29], China [15], South Africa [18]
Absence of a counseling space: UK [11], Belgium [24], Canada [17], South Africa [18], Mal [34]
Absence of a principle model as a merit procedure for CPs: Canada [17], Russia [10], UAE [22], Mal [30]
Lack of confidence and trust among GPs: Mal [32, 36, 37]
Gender barrier: Mal [33]
Health promotion which is carried out by the customers: Mal [30]
GPs, general practitioners; CPs, community pharmacists; HK, Hong Kong; UAE, United Arab Emirates; Sin, Singapore; 
Aust, Australia; UK, United Kingdom; Mal, Malaysia; CPs, community pharmacists; HPs, healthcare providers; #, 
number.
Table 3. Details of countries which indicate barriers toward performance of extended pharmacy services.
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commencing a wide range of extended services. Therefore, it is notified that some customers 
in Australia refuse to reimburse CPs for such services. Consequently, it is crucial to take into 
account of consumers to be members of policymaker so that their official spokesman can give 
intellectual, moral, and instruction to the society about the benefits of such extended services.
Foremost, GPs and consumers must acknowledge the role of CPs as the supreme medication 
protector in the healthcare system. Their feeling and belief might make the extended services 
look more attractive or otherwise. Therefore, it is critical to determine their point of views 
regarding the provision of extended services in community pharmacy settings. As illustrated 
in Table 4, it is notified that CPs in the United Kingdom, Australia, Hong Kong, South Africa, 
the United Arab Emirates, and Sudan have taken into account of collaborating with GPs to 
Perception of extended services: Country published (Article #)
Customers rarely adjudge the community pharmacy as a healthcare facility: Jordan [14]
Having a tendency to minimize the general practitioners’ overburden duties: Aust [13]
Supporting from the pharmacy associations to exercise such extended services: UK [11], Aust [16]
Government’s rule to execute such extended services: UK [11]
A solution to the shortage of general practitioners: UK [11]
Reimbursement scheme for such extended service: UK [11]
Determine to exercise their knowledge and skills: UK [11], Nepal [25], Aust [16], South Africa [18], Sudan [23]
Determine to experience a new challenge in an on-going practice: UK [11]
Advancing personal marketability: UK [11]
A duty to take more responsibilities with their medication action plan: UK [11], South Africa [18]
A potential to establish a working relationship with other healthcare providers: UK [11], Aust [16], HK [27], South 
Africa [18], UAE [21], Sudan [23], Mal [31, 33, 36, 37]
Magnifying the superior image of pharmacy practice: UK [11], South Africa [18], Mal [33]
A part to enlarge on-going career: UK [11]
Benefit the profession in many aspects: UK [11], South Africa [18]
Personal satisfaction: UK [11], Nepal [25]
Benefit the customers: UK [11], Nepal [25], Sudan [23]
Improving sales: Nepal [25], UAE [20]
A strategic plan to eliminate business competition: Nepal [25], UAE [20]
GPs are not favor of CPs to conduct the smoking cessation program: Mal [32]
GPs are favor of CPs to determine the drug-related problems: Mal [32]
GPs are willing to work side-by-side with CPs to review medication outcome: Mal [31, 32]
GPs are aware of CPs more toward patient-oriented profession: Mal [31]
GPs are not favor of CPs to document customers’ profiles: Mal [31]
GPs are not favor of CPs to recorrect written prescriptions themselves: Mal [31]
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operate such extended services. Such working relationship might bring benefits to consum-
ers at all. For example, it is notified in an earlier study which signifies that such relationship 
can be a service to superintend hypertension patients [47]. Additionally, it is noted that such 
relationship in managing more chronic diseases have been reflected in an earlier review article 
[9]. Nevertheless, such working relationship might have potential to summon misconception in 
the responsibilities of both parties as notified in an earlier study [48]. Therefore, it is necessary 
to initiate a constructive strategy to fortify such working relationship in the healthcare system 
[49]. The strategy formula must have a conceptual framework as a general guiding principle to 
make it easier for CPs to work side-by-side with GPs. For that reason, an instrument is known 
as STARZ-DRP put into operation as a course of action to enroll both healthcare providers into 
a strategy medical team [50].
5. STARZ-DRP as a tool to attach GPs and CPs in the identical 
practice
It is necessary to have a fundamental procedure to follow in advanced prior to execute the 
other extended services. The procedure should help out CPs to have an initial idea regarding 
each individual feature acquired via counseling session. In other words, it is crucial for CPs 
to make an accurate triage action plan as an earlier extended service based on the up-to-date 
information. For example, the idea to refer the customers to GPs for immediate medical atten-
tion should be the first in the sequence of making a triage action plan. Such ethical responsi-
bilities might have potential to save the customers’ life from inappropriate medication use. 
GPs are favor of CPs to refer customers to them: Mal [31, 32]
CPs are not regarded as the best practitioner to advise GPs about the rationale medication use: Mal [31, 32]
GPs should listen to CPs about written prescriptions’ issues: Mal [31, 32]
CPs are not well trained to perform screening tests: Mal [31]
GPs are favor of CPs to treat minor ailments: Mal [31, 32]
CPs are underestimated by GPs: Mal [31]
CPs’ knowledge and skills are underutilized: Mal [32]
CPs are not well trained in clinical therapeutic knowledge: Mal [31]
Customers appreciate extended services: Mal [33, 35]
CPs are potential to counsel about health screening: Mal [33, 35]
CPs are the best practitioner to educate about medications: Mal [31, 32]
CPs should involve in health promotion: Mal [32, 33, 35]
GPs, general practitioners; CPs, community pharmacists; Aust, Australia; UK, United Kingdom; UAE, United Arab 
Emirates; Mal, Malaysia; HK, Hong Kong.
Table 4. Details of countries which indicate perception of extended pharmacy services.
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The following sequence is to help out CPs to make a medication therapy plan. It might involve 
CPs and customers to sit down and start to determine the ideal medication to alleviate the 
on-going minor ailments or maintain the current health status. Consequently, this sequence 
is magnifying the role of CPs as an adviser to the customers. The last sequence in a triage 
action plan is to help out CPs to assist their customers to experience the other extended phar-
macy services which are available in community pharmacy settings as illustrated in Table 2. 
The main intention is to help out the customers to enhance their quality of life via CPs’ knowl-
edge and skills. Furthermore, the knowledge and skills might have potential to add on more 
value to an earlier medical treatment or else. As a consequence, it is critical for CPs to start out 
this triage action mode as a fundamental extended service in advance. Therefore, STARZ-DRP 
is picked up as the appropriate fundamental procedure to follow via experience in an earlier 
study [43]. Foremost, STARZ-DRP is helping out CPs to execute the role as the supreme medi-
cation protector via determining the drug-related problem (DRP) which might have poten-
tial to be the origin of actual or potential medical problem [50]. As a consequence, it is the 
opportunity for CPs to interact with GPs to discuss in detail about the DRP which might be 
experienced by the customers.
STARZ-DRP is a simple mnemonic to remember and it is initiated to make it easier for CPs 
to make an accurate triage action plan and distinguish the origins of DRP [50]. As illustrated 
in Table 5, the mnemonic integrates several words which are entitled to act as an action to 
Letter Description
S Symptom presentation refers to subjective evidence of health problem perceived by the patient
T Time of onset and duration of the present symptoms
A Associated symptoms refer to patient symptoms explored and determined by the pharmacist during the 
interview. It does not refer to the symptoms presented earlier by the patient. This is done by using the 
pictorial documentation form as depicted in Figure 1. To aid and ease the pharmacist during the interview, 
the human body is arbitrarily divided into four regions: (i) Front: the part of the body facing the pharmacist 
(asking for symptoms like bloating, heartburn, nausea, vomiting, breathlessness, etc.), (ii) Back: (asking 
for symptoms like lower and upper back pain, shoulder pain, and neck pain), (iii) Upper (head) (asking 
for symptoms like headache, dizziness, problems with sleep, etc.), (iv) Lower (asking for symptoms like 
numbness in both legs and hands, constipation, and swollen feet). Perhaps, the method is likened to a 
filtering or screening process to rule out the presence of severe symptoms.
R Recurrence problem refers to the symptoms have been treated before, specifically when the symptoms recur 
and persist despite the treatment prescribed.
Z Zoom into the patient’s medication experience refers to information collected by the pharmacist related to 
any medical problems (e.g., hypertension, diabetes, hyperthyroid, etc.), medication utilization (e.g., use of 
prescription and non-prescription drugs, and herbal supplements), immunization history, allergies, drug 
sensitivities, drug side effects, adverse reactions, and the consumption of alcohol, caffeine, and tobacco.
#This is not a diagnostic tool, rather it is a format with the purpose of organizing a community pharmacist’s knowledge 
in a manner that allows him/her to begin identifying the actual and potential drug-related problems and subsequently 
referring triage patients to the appropriate healthcare professionals.
*The patient’s vital signs will be measured when necessary. At times, the patient’s blood pressure, pulse rate, and body 
temperature are measured to aid the pharmacist in assessing the appropriateness of symptoms for self-medication.
Table 5. Definition of letters in STARZ #,*.
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Figure 3. Pharmacy self-care advice form.
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scrutinize customer features. CPs are necessary to act in the same direction while operating 
the appraisal via the tool and it is prohibited to ignore a single word in STARZ-DRP. For 
example, there is an inclination toward a particular word in STARZ-DRP such as ‘A’ since it 
Figure 4. Patient referral form.
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is not a  conventional practice to assess such features. However, it is notified that such precise 
word might help CPs to determine critical signs and symptoms that require instant medi-
cal attention [51]. On top of that, CPs shall not fail to hit the single word is known as ‘Z’ in 
STARZ-DRP. Such a single word is the paramount importance to determine the origins of 
actual and potential drug-related problems. It has been notified in an earlier study regarding 
the potential of CPs to determine, counteract, and rectify drug-related problems [52]. In the 
authentic practice, the role to determine the origins of drug-related problems is the rightful 
possession of CPs. Furthermore, CPs are the supreme medication protector who are trained 
in superintending medication affairs in the healthcare system.
STARZ-DRP has been initiated in a printed paper as illustrated in Figure 3. The main objec-
tive is to make easier for CPs to transcript the verbal data of customer features into a writ-
ten version. Such a proceeding is to facilitate CPs to reminisce about earlier events when 
CPs counsel their customers during a follow-up session. Consequently, the proceeding might 
precipitate CPs to determine the successful result of the previous triage action plan. In other 
words, CPs might have to initiate another alternative triage action plan if the earlier blueprint 
disappoints to wipe out the origins of the medical and medication affair. In such authentic 
practice, a referral to GPs must be carried out using the form as illustrated in Figure 4 in order 
to request for advanced medical examination or advice. Interestingly, CPs can put in writing 
about their earlier observation so that GPs will have some ideas about the customers.
An earlier study has pointed out that CPs’ knowledge and skills to make a triage action plan are 
ameliorated after CPs emerged in a STARZ-DRP training [53]. Additionally, significant differ-
ences are noted in some of the knowledge and skills after weighing up the mean scores of pre- 
and post-training. Among the significant differences, the self-confidence to assess and determine 
individual features that acquire immediate medical attention or non-prescription medications 
are noted. As a consequence, it is an aspiration if CPs can determine STARZ-DRP as a potential 
mode of action to execute the initial extended service in community pharmacy settings.
Sincerely, such proceeding should be reimbursed with appropriate dollars as it takes CPs to 
perform their knowledge and skills to determine the triage action plan and origins of drug-
related problems. In addition, CPs have to spend their time to interact with their customers 
via the proceeding. Foremost, CPs should be adjudged as a supreme healthcare practitioner 
in determining all medication affairs in the healthcare system.
6. Limitation to the use of STARZ-DRP in the authentic practice
In general, STARZ-DRP might not have potential to help out CPs to execute extended ser-
vices unless CPs are well trained in clinical therapeutic knowledge. Such knowledge should 
come into possession via higher pharmacy education in the university. In the absence of such 
knowledge, CPs might not have self-confidence to interact with customers. Subsequently, CPs 
might also have potential to keep distance from GPs as a way to avoid being cross-examined 
regarding the customers’ medication affairs. As a consequence, it is necessary to initiate a 
strategy formula to add in more clinical therapeutic knowledge in the pharmacy program.
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Additionally, STARZ-DRP acquires CPs to retain possession of customer features in a printed 
paper as illustrated in Figure 3. Subsequently, there is a potential to experience some issues 
like unable to track down the printed paper because it is not in its expected place or absence 
of a proper cabinet to put aside all printed papers. Therefore, in the near future, STARZ-DRP 
might have potential to be exercised via a softcopy version. Such a legible version might elimi-
nate the issues as noted in advanced. As a consequence, STARZ-DRP is eligible for CPs who 
might have an interest to sustain their authentic practice in up-to-date scenario.
Foremost, STARZ-DRP acquires CPs to allocate a few moments in their life to interact with the 
customers in order to understand about their features. Failure to execute the moments might 
have potential to put an end to other extended services. Therefore, it is crucial for CPs to have 
motivating force to perform STARZ-DRP as a mode of action. In the scenario, the pharmaceutical 
association should take the responsibilities to convince the policymakers to enforce a regulation 
for CPs to make an accurate triage action plan for each customer. The policymakers should have 
absolute understanding that STARZ-DRP might have potential to benefit the customers at all.
Aftermost, CPs must allocate a space for a private conversation with their customers. It is 
necessary to have the private room in order to protect the information obtained via the con-
versation to be heard by other customers. Subsequently, it might have potential to ease the 
customers to voice out their features to CPs. As a consequence, CPs might have the opportu-
nity to determine an appropriate triage action plan.
7. Benefits via STARZ-DRP model
STARZ-DRP is a conceptual framework for CPs and it emerges from the concept of PC which 
acquires CPs to determine DRP among the customers who are on short- or long-term treat-
ment. STARZ-DRP had been incorporated into an earlier study in order to look into its fea-
sibility to be put into practice in non-hospital independent facilities [50]. Interestingly, the 
model is able to coach CPs to determine a wide range of DRP as well as help out CPs to initiate 
an accurate triage action plan. Consequently, the end result is bringing to the public atten-
tion about the competence of the model to be the course of actions for CPs in their on-going 
practice. Subsequently, the model is on the right track to reject the idea as a theoretical work.
In general, STARZ-DRP is actually helping out CPs to market their critical accountability as a 
supreme medication protector in the healthcare system. In other words, CPs must make sure 
that each customer is accessible to a wide range of medications which its safety, effectiveness, 
quality, and cost-effective are protected. It might involve the customers who are on short- or 
long-term treatment. Consequently, the role might have potential to magnify the image of 
CPs in the healthcare system. Moreover, the model acquires CPs to be more responsible with 
each decision made. Therefore, the model is practical to be put into the on-going practice 
despite different languages, culture, and healthcare modus operandi.
Moreover, STARZ-DRP might have potential to help out CPs in Malaysia to market their posi-
tion as a healthcare provider after CPs are taken into account as an entrepreneur for such a long 
time [3]. STARZ-DRP might show the way for CPs to determine the basic extended service 
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prior to other extended services in advanced. Subsequently, STARZ-DRP might have poten-
tial to influence CPs to add in more values into their conservative exercise. As a consequence, 
the scenario might attract the attention of other healthcare providers, policymakers, and cus-
tomers to put their absolute trust on CPs to manage all medication affairs. Otherwise, the other 
medical practitioners like doctor and nurse might take the chance to market their knowledge 
and skills via managing the medication affairs. At the end, CPs will have to breathe harder in 
order to sustain their existing in the healthcare system.
CPs must move forward to market their expertise in dissimilar extended services. It is neces-
sary to have such mission and vision in order to sustain their values in the eye of other health-
care providers, policymakers, and customers. It is noted in an earlier study that STARZ-DRP 
might have potential to eliminate a wide range of DRP in the community pharmacy settings 
[43]. Such a role points out that CPs can perform the identical exercise like the clinical phar-
macists in the hospital settings. Subsequently, in the near future, it is necessary to review the 
definition of clinical pharmacists for the non-hospital settings. As a consequence, it might have 
potential to eliminate the image as an entrepreneur and put into the frame the image as a 
respected healthcare provider.
8. Conclusion
It is notified that CPs can market their knowledge and skills via a wide range of extended 
service. Nevertheless, CPs must determine the origins of barriers toward such extended ser-
vices and perceptions of the services in the eyes of customers and GPs. Consequently, CPs 
have to initiate a strategy formula to eliminate such barriers and perceptions. It is noted that 
STARZ-DRP is an applicable model to help out CPs to commerce an earlier extended service 
via the role as a ‘gate-keeper’. Additionally, STARZ-DRP might have potential to show the 
way the exact mode of action prior to other extended services in advanced. The rationale of 
the article is the fact that it might have potential to help out CPs to incorporate the concept of 
PC into their on-going practice. Moreover, the model as noted in advance is able to integrate 
CPs with GPs and work side-by-side for the sake of the customers. Subsequently, the model 
might have potential to magnify the image of CPs as a supreme medication protector in the 
healthcare system.
Acknowledgements
We are grateful to those who make it easier for us to put the finishing touches on this article.
Conflict of interest
Authors declare no conflict of interest in the study.
Marketing144
Notes
Thanks to Nazri Nordin, the doctoral degree (PhD) candidate who has put his effort to finish 
up this article on time.
Author details
Mohamed Azmi Hassali*, Nazri Nordin, Azmi Sarriff and Fahad Saleem
*Address all correspondence to: azmihassali@gmail.com
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia
References
[1] Kimura T, Ogura F, Yamamoto K, Uda A, Nishioka T, Kume M, Makimoto H, Yano 
I, Hirai M. Potentially inappropriate medications in elderly Japanese patients: Effects 
of pharmacists' assessment and intervention based on screening tool of older Persons' 
potentially inappropriate prescriptions criteria ver.2. Journal of Clinical Pharmacy and 
Therapeutics. 2017;42(2):209-214. DOI: 10.1111/jcpt.12496
[2] Onatade R, Auyeung V, Scutt G, Fernando J. Potentially inappropriate prescribing in 
patients on admission and discharge from an older peoples' unit of an acute UK hospital. 
Drugs & Aging. 2013;30(9):729-737. DOI: 10.1007/s40266-013-0097-5
[3] Nordin N, Hassali MA, Sarriff A. Actual or potential extended services performed by 
Malaysian community pharmacists, perceptions and barriers towards it’s performance: 
A systematic review. International Journal of Pharmacy and Pharmaceutical Sciences. 
2017;9(10):13-20. DOI: 10.22159/ijpps.2017v9i10.20694
[4] O'Sullivan DP, O'Mahony D, Parsons C, Hughes C, Murphy K, Patterson S, Byrne S. A 
prevalence study of potentially inappropriate prescribing in Irish long-term care resi-
dents. Drugs & Aging. 2013;30(1):39-49. DOI: 10.1007/s40266-012-0039-7
[5] Phipps DL, Noyce PR, Parker D, Ashcroft DM. Medication safety in community phar-
macy: A qualitative study of the sociotechnical context. BMC Health Services Research. 
2009;9:158. DOI: 10.1186/1472-6963-9-158
[6] Young SW, Bishop LD, Conway A. Interventions performed by community pharma-
cists in one Canadian province: A cross-sectional study. Therapeutics and Clinical Risk 
Management. 2012;8:415-421. DOI: 10.2147/TCRM.S37581
[7] Bell JS, Vaananen M, Ovaskainen H, Narhi U, Airaksinen MS. Providing patient 
care in community pharmacies: Practice and research in Finland. The Annals of 
Pharmacotherapy. 2007;41(6):1039-1046
Community Pharmacy Marketing in the New Era: A Global Picture of Extended Community…
http://dx.doi.org/10.5772/intechopen.74326
145
[8] Nordin N, Hassali MA, Sarriff A. A global picture of extended pharmacy services, per-
ceptions and barriers towards its performance: A systematic review. Asian Journal of 
Pharmaceutical and Clinical Research. 2017;10(11):417-427. DOI: 10.22159/ajpcr.2017.
v10i11. 19884
[9] George PP, Molina JAD, Cheah J, Chan SC, Lim BP. The evolving role of the commu-
nity pharmacist in chronic disease management – A literature review. Annals of the 
Academy of Medicine, Singapore. 2010;39:861-867
[10] Egorova SN, Akhmetova T. Pharmaceutical counseling: Between evidence-based medi-
cine and profits. The International Journal of Risk & Safety in Medicine. 2015;27(Suppl 1): 
S87-S88
[11] Warchal S, Brown D, Tomlin N, et al. Attitudes of successful candidates of supplemen-
tary prescribing courses to their training and their extended roles. The Pharmaceutical 
Journal. 2006;276:348-352
[12] Ahmad A, Hugtenburg J, Welschen LMC, et al. Effect of medication review and cogni-
tive behaviour treatment by community pharmacists of patients discharged from the 
hospital on drug related problems and compliance: Design of a randomized controlled 
trial. BMC Public Health. 2010;10:133
[13] Berbatis CG, Sunderland VB, Joyce A, et al. Enhanced pharmacy services, barriers 
and facilitators in Australia's community pharmacies: Australia's National Pharmacy 
Database Project. The International Journal of Pharmacy Practice. 2007;15(3):185-191
[14] Al-Wazaify M, Albsoul-Younes A. Pharmacy in Jordan. American Journal of Health-
System Pharmacy. 2005;62:2548-2551
[15] Fang Y, Yang S, Zhou S, et al. Community pharmacy practice in China: Past, present and 
future. International Journal of Clinical Pharmacy. 2013;35(4):520-528
[16] Hoti K, Hughes J, Sunderland B. An expanded prescribing role for pharmacists – An 
Australian perspective. The Australasian Medical Journal. 2011;4(4):236-242
[17] Laliberte MC, Perreault S, Damestoy N, et al. Ideal and actual involvement of commu-
nity pharmacists in health promotion and prevention: A cross-sectional study in Quebec, 
Canada. BMC Public Health. 2012;12:192
[18] Malangu N. The future of community pharmacy practice in South Africa in the light of 
the proposed new qualification for pharmacists: Implications and challenges. Global. 
Journal of Health Science. 2014;6(6):226-233
[19] Rayes IK, Hassali MA, Abduelkarem AR. The role of pharmacists in developing coun-
tries: The current scenario in the United Arab Emirates. Saudi Pharmaceutical Journal. 
2015;23:470-474
[20] Rayes IK, Hassali MA, Abduelkarem AR. Perception of community pharmacists towards 
the barriers to enhanced pharmacy services in the healthcare system of Dubai: A quanti-
tative approach. Pharmacy in Practice. 2015;13(2):506
[21] Rayes IK, Abduelkarem AR. A qualitative study exploring physicians’ perceptions on 
the role of community pharmacists in Dubai. Pharmacy in Practice. 2016;14(3):738
Marketing146
[22] Sadek MM, Elnour AA, Al Kalbani NMS, et al. Community pharmacy and the extended 
community pharmacist practice roles: The UAE experiences. Saudi Pharmaceutical 
Journal. 2016;24(5):563-570
[23] Salim AM, Elgizoli B. Exploring self-perception of community pharmacists of their pro-
fessional identity, capabilities and role expansion. Journal of Pharmacy Practice and 
Research. 2016;5(2):116-120
[24] Scheerder G, De Coster I, Van Audenhove C. Pharmacists’ role in depression care: A sur-
vey of attitudes, current practices, and barriers. Psychiatric Services. 2008;59:1155-1161
[25] Poudel A, Khanal S, Kadir A, et al. Perception of Nepalese community pharmacists 
towards patient counseling and continuing pharmacy education program: A multicen-
tric study. Journal of Clinical and Diagnostic Research. 2009;3:1408-1413
[26] Wada Y, Wada Y, Ennyu S, et al. Ability of community pharmacists to promote self-care 
and self-medication by local residents [I]: Improvements in bone mineral density. Drug 
Discoveries & Therapeutics. 2017;11(1):35-40
[27] Wong FYY, Chan FWK, You JHS, et al. Patient self-management and pharmacist-led 
patient self-management in Hong Kong: A focus group study from different healthcare 
professionals’ perspectives. BMC Health Services Research. 2011;11:121
[28] Yamamura S, Yamamoto N, Oide S, et al. Current state of community pharmacy 
in Japan: Practice, research, and future opportunities or challenges. The Annals of 
Pharmacotherapy. 2006;40(11):2008-2014
[29] You JH, Wong FY, Chan FW, et al. Public perception on the role of community phar-
macists in self-medication and self-care in Hong Kong. BMC Clinical Pharmacology. 
2011;11:19
[30] Hassali MA, Subish P, Shafie AA, Ibrahim MIM. Perceptions and barriers towards pro-
vision of health promotion activities among community pharmacists in the state of 
Penang, Malaysia. Journal of Clinical and Diagnostic Research. 2009;3:1562-1568
[31] Hassali MA, Awaisu A, Shafie AA, Saeed MS. Professional training and roles of com-
munity pharmacists in Malaysia: Views from general medical practitioners. Malaysian 
Family Physician. 2009;4:71-76
[32] Azmi S, Nazri N, Azmi AH. Extending the roles of community pharmacists: Views from 
general medical practitioners. The Medical Journal of Malaysia. 2012;67:574-578
[33] Beshir SA, Hanipah MA. Knowledge, perception, practice and barriers of breast cancer 
health promotion activities among community pharmacists in two districts of Selangor 
state, Malaysia. Asian Pacific Journal of Cancer Prevention. 2012;13:4427-4430
[34] Rajiah K, Kaur KP, Sivarasa S, Ming LY. Perception of community pharmacists towards 
patient counseling and continuing pharmacy education program in Kuala Lumpur 
and Selangor states of Malaysia. American Journal of Pharmacy and Health Research. 
2014;2:48-56
[35] Sarriff A, Amin AM, Mostafa H. Public knowledge and awareness of cardiovas-
cular diseases and the expected role of community pharmacists in the prevention 
Community Pharmacy Marketing in the New Era: A Global Picture of Extended Community…
http://dx.doi.org/10.5772/intechopen.74326
147
and management of cardiovascular diseases in Penang, Malaysia. CMU Journal of 
Natural of Sciences. 2014;13:355-369
[36] Saw PS, Nissen L, Freeman C, Wong PS, Mak V. Exploring the role of pharmacists in pri-
vate primary healthcare clinics in Malaysia: The views of general practitioners. Journal 
of Pharmacy Practice and Research. 2017;47:27-33
[37] Saw PS, Nissen LM, Freeman C, Wong PS, Mak V. Health care consumers’ perspectives 
on pharmacist integration into private general practitioner clinics in Malaysia: A qualita-
tive study. Patient Prefer Adherence. 2015;9:467-477
[38] Saira A, Mohamed Azmi H, Mohamed Izham MI, et al. The role of pharmacists in 
developing countries: The current scenario in Pakistan. Human Resources for Health. 
2009;7:54
[39] Alvarez-Risco A, van Mil JW. Pharmaceutical care in community pharmacies: Practice 
and research in Peru. The Annals of Pharmacotherapy. 2007;41(12):2032-2037
[40] Volmer D, Vendla K, Vetka A, Bell JS, Hamilton D. Pharmaceutical care in commu-
nity pharmacies: Practice and research in Estonia. The Annals of Pharmacotherapy. 
2008;42(7):1104-1111. DOI: 10.1345/aph.1K644
[41] Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernandez D. Impact of 
a community pharmacists' hypertension-care service on medication adherence. The 
AFenPA study. Research in Social & Administrative Pharmacy. 2013;9(6):797-805. DOI: 
10.1016/j.sapharm.2012.12.006
[42] Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, 
Stewart K, Taylor S, Wilkinson J. The pharmacy diabetes care program: Assessment 
of a community pharmacy diabetes service model in Australia. Diabetic Medicine. 
2007;24(6):677-683
[43] Nordin N, Hassali MA, Sarriff A. STARZ-DRP: A tool for pharmacy triage services. Asian 
Journal of Pharmaceutical and Clinical Research. 2017;10(10):151-157. DOI: 10.22159/
ajpcr.2017.v10i10.19857
[44] Saba M, Diep J, Saini B, Dhippayom T. Meta-analysis of the effectiveness of smoking 
cessation interventions in community pharmacy. Journal of Clinical Pharmacy and 
Therapeutics. 2014;39(3):240-247. DOI: 10.1111/jcpt.12131
[45] Houle SKD, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient 
care: A systematic review of remunerated pharmacy clinical care services. Canadian 
Pharmacists Journal (Ott). 2014;147(4):209-232. DOI: 10.1177/1715163514536678
[46] Nordin N, Hassali MA, Sarriff A. STARZ-DRP as a triaging tool for community pharma-
cists: Perspectives and expectations of stakeholders. International Journal of Pharmacy 
and Pharmaceutical Sciences. 2017;9(11):81-86. DOI: 10.22159/ijpps.2017v9i11.20876
[47] West R, Isom M. Management of patients with hypertension: General practice and 
community pharmacy working together. The British Journal of General Practice. 
2014;64(626):477-478. DOI: 10.3399/bjgp14X681553
Marketing148
[48] Wustmann AF, Haase-Strey C, Kubiak T, Ritter CA. Cooperation between commu-
nity pharmacists and general practitioners in eastern Germany: Attitudes and needs. 
International Journal of Clinical Pharmacy. 2013;35(4):584-592. DOI: 10.1007/s11096- 
013-9772-1
[49] Jove AM, Fernandez A, Hughes C, Guillen-Sola M, Rovira M, Rubio-Valera M. Percep-
tions of collaboration between general practitioners and community pharmacists: 
Findings from a qualitative study based in Spain. Journal of Interprofessional Care. 
2014;28(4):352-357. DOI: 10.3109/13561820.2014.898621
[50] Sarriff A, Nordin N, Hassali MA. STARZ-DRP: A step-by-step approach for pharmacy 
triage services. Malaysian Journal of Pharmaceutical Sciences. 2011;1(9):311-325
[51] Holland R. When to Refer. Pharmaceutical Society of Australia; 1993. p. 15
[52] Hammerlein A, Griese N, Schulz M. Survey of drug-related problems identified by com-
munity pharmacies. The Annals of Pharmacotherapy. 2007;41(11):1825-1832
[53] Nordin N, Hassali MA, Sarriff A. STARZ-DRP: A structured framework for teaching com-
munity pharmacists to counsel self-care customers. International Journal of Pharmacy 
and Pharmaceutical Sciences. 2017;9(12):271-275. DOI: 10.22159/ijpps.2017v9i12.22330
Community Pharmacy Marketing in the New Era: A Global Picture of Extended Community…
http://dx.doi.org/10.5772/intechopen.74326
149

